Literature DB >> 14598182

Immune hemolysis-serological and clinical aspects.

A Pruss1, A Salama, N Ahrens, A Hansen, H Kiesewetter, J Koscielny, T Dörner.   

Abstract

The differential diagnosis of anemia must consider immune hemolytic anemias as a frequent cause. Whereas detection of anti-red blood cell (RBC) alloantibodies frequently induced by immunogenic stimuli (transfusion, pregnancy) is performed by routine serology, diagnosing autoimmune hemolytic anemias or drug-induced hemolytic anemias remains a challenge, usually requiring close collaboration of a number of disciplines. Positive direct antiglobulin test (Coombs' test) represents a central criterion in diagnosing immune hemolytic anemias, leading to further detailed analyses. The most-severe type of immune-mediated hemolysis is acute intravascular hemolysis after ABO incompatible RBC transfusion. This review highlights underlying biochemical aspects, immunohematological diagnostics, and the clinical relevance of RBC allo- and autoantibodies, including paroxysmal nocturnal hemoglobinemia and drug-induced hemolysis. Finally, current and partly experimental therapeutic strategies of immune hemolytic anemias are summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598182     DOI: 10.1007/s10238-003-0009-4

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  7 in total

1.  Induction of heme oxygenase-1 and ferritin in the kidney in warm antibody hemolytic anemia.

Authors:  Fernando C Fervenza; Anthony J Croatt; Camila M Bittar; David W Rosenthal; Donna J Lager; Nelson Leung; Steven R Zeldenrust; Karl A Nath
Journal:  Am J Kidney Dis       Date:  2008-09-21       Impact factor: 8.860

Review 2.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

3.  A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.

Authors:  Clifford T Mauriello; Haree K Pallera; Julia A Sharp; Jon L Woltmann; Shizhi Qian; Pamela S Hair; Pieter van der Pol; Cees van Kooten; Nicole M Thielens; Frank A Lattanzio; Kenji M Cunnion; Neel K Krishna
Journal:  Mol Immunol       Date:  2012-08-18       Impact factor: 4.407

4.  Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia.

Authors:  Christine J Piek; Erik Teske; Martin W van Leeuwen; Michael J Day
Journal:  Acta Vet Scand       Date:  2012-02-08       Impact factor: 1.695

5.  Intravenous artesunate for severe malaria in travelers, Europe.

Authors:  Thomas Zoller; Thomas Junghanss; Annette Kapaun; Ida Gjorup; Joachim Richter; Mats Hugo-Persson; Kristine Mørch; Behruz Foroutan; Norbert Suttorp; Salih Yürek; Holger Flick
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

6.  Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies.

Authors:  James Shaw; Ian W Gibson; Chris Wiebe; Donald S Houston; Joshua Koulack; David Rush; Peter Nickerson; Julie Ho
Journal:  Transplant Direct       Date:  2019-07-25

7.  Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma.

Authors:  Hongkai Lu; Na Wang; Peng Wang; Haolin Zhang; Ru Zhao; Hongju Liu; Xirong He; Zeya Liu; Yue Chang; Yongtong Cao; Shiyao Wang
Journal:  Front Med (Lausanne)       Date:  2022-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.